Fourier-Transform MS for Top Down Proteomics

Similar documents
A Complete Workflow Solution for Intact Monoclonal Antibody Characterization Using a New High-Performance Benchtop Quadrupole- Orbitrap LC-MS/MS

Monoclonal Antibody Characterization on Q Exactive and Oribtrap Elite. Yi Zhang, Ph.D Senior Proteomic Marketing Specialist Oct.

Fast and Efficient Peptide Mapping of a Monoclonal Antibody (mab): UHPLC Performance with Superficially Porous Particles

High Resolution Accurate Mass Peptide Quantitation on Thermo Scientific Q Exactive Mass Spectrometers. The world leader in serving science

Precise Characterization of Intact Monoclonal Antibodies by the Agilent 6545XT AdvanceBio LC/Q-TOF

PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mabs and ADC

Thermo Scientific Solutions for Intact-Protein Analysis. Better, Faster Decisions for. Biotherapeutic Development

A Unique LC-MS Assay for Host Cell Proteins(HCPs) ) in Biologics

Top reasons to upgrade to a Q Exactive HF-X hybrid quadrupole-orbitrap mass spectrometer

Expand Your Research with Metabolomics and Proteomics. Christine Miller Omics Market Manager ASMS 2017

Rapid Peptide Mapping via Automated Integration of On-line Digestion, Separation and Mass Spectrometry for the Analysis of Therapeutic Proteins

mabs and ADCs analysis by RP

LTQ Orbitrap XL Hybrid FT Mass Spectrometer Unrivaled Performance and Flexibility

Detecting Challenging Post Translational Modifications (PTMs) using CESI-MS

Thermo Scientific Peptide Mapping Workflows. Upgrade Your Maps. Fast, confident and more reliable peptide mapping.

Liver Mitochondria Proteomics Employing High-Resolution MS Technology

Highly Confident Peptide Mapping of Protein Digests Using Agilent LC/Q TOFs

Proteomics. Proteomics is the study of all proteins within organism. Challenges

High-Throughput Peptide Mapping with the Vanquish UHPLC System and the Q Exactive HF Mass Spectrometer

Application Note. Kwasi Antwi, Amanda Ribar, Urban A. Kiernan, and Eric E. Niederkofler Thermo Fisher Scientific, Tempe, Arizona

Enabling Systems Biology Driven Proteome Wide Quantitation of Mycobacterium Tuberculosis

Key Words Q Exactive Focus, SIEVE Software, Biomarker, Discovery, Metabolomics

Využití cílené proteomiky pro kontrolu falšování potravin: identifikace peptidových markerů v mase pomocí LC- Q Exactive MS/MS

Application of Agilent AdvanceBio Desalting-RP Cartridges for LC/MS Analysis of mabs A One- and Two-dimensional LC/MS Study

Advantages of Ion Mobility QTOF for Characterization of BioPharma Molecules

N-Glycan Profiling Analysis of a Monoclonal Antibody Using UHPLC/FLD/Q-TOF

Maximizing Chromatographic Resolution of Peptide Maps using UPLC with Tandem Columns

Improving Sensitivity in Bioanalysis using Trap-and-Elute MicroLC-MS

Development of Analysis Methods for Therapeutic Monoclonal Antibodies Using Innovative Superficially Porous Particle Biocolumns

Understanding life WITH NEXT GENERATION PROTEOMICS SOLUTIONS

BioHPLC columns. Tim Rice Biocolumn Technical Specialist

Application Note # ET-20 BioPharma Compass: A fully Automated Solution for Characterization and QC of Intact and Digested Proteins

Thermo Scientific EASY-nLC 1200 System. Leading in simplicity. and performance

Identification of Microprotein-Protein Interactions via APEX Tagging

Structure Characterization and Differentiation of Biosimilar and Reference Products Using Unique Combination of Complementary Fragmentation Mechanisms

CaptiveSpray nanobooster

Proteins. Patrick Boyce Biopharmaceutical Marketing Manager Waters Corporation 1

Antibody Analysis by ESI-TOF LC/MS

rapiflex Innovation with Integrity Designed for Molecules that Matter. MALDI TOF/TOF

Method Development Considerations for Reversed-Phase Protein Separations

ENCODE DCC Antibody Validation Document

faster, confident more path to all the information in your samples. Agilent MassHunter Workstation Software Our measure is your success.

Asish Chakraborty, St John Skilton, Weibin Chen and John C. Gebler Waters Corporation, Milford, MA, U.S. INTRODUCTION METHODS. Sample preparation

The Effect of MS/MS Fragment Ion Mass Accuracy on Peptide Identification in Shotgun Proteomics

Application Note. Author. Abstract. Biotherapeutics and Biologics. Sonja Schneider Agilent Technologies, Inc. Waldbronn, Germany

Application Note LCMS-87 Automated Acquisition and Analysis of Data for Monitoring Protein Conjugation by LC-MS Using BioPharma Compass

Rapid Peptide Catabolite ID using the SCIEX Routine Biotransform Solution

Rapid Soft Spot Analysis using the SCIEX Routine Biotransform Solution

DISCOVERY AND VALIDATION OF TARGETS AND BIOMARKERS BY MASS SPECTROMETRY-BASED PROTEOMICS. September, 2011

Advances in analytical biochemistry and systems biology: Proteomics

Using HRAM Survey Analysis Combined with Rapid MS2 Data to Develop a Fragmentation Based Detection Workflow for Structure ID Acquisition

The clearly better choice

Characterize Fab and Fc Fragments by Cation-Exchange Chromatography

Thermo Scientific TSQ Quantiva Triple-Stage Quadrupole Mass Spectrometer. Extreme quantitative performance. with unprecedented ease

Tony Mire-Sluis Vice President, Corporate, Product and Device Quality Amgen Inc

ADVANCE ACCURACY AND PRODUCTIVITY FOR FASTER ANALYSIS

Two-Dimensional LC Protein Separation on Monolithic Columns in a Fully Automated Workflow

Analysis of Glyphosate and AMPA in Environmental Water Samples by Ion Chromatography and On-Line Mass Spectrometry with Minimal Sample Preparation

SMART Digest Kit User Manual. Version 2

Center for Mass Spectrometry and Proteomics Phone (612) (612)

MBios 478: Mass Spectrometry Applications [Dr. Wyrick] Slide #1. Lecture 25: Mass Spectrometry Applications

Characterization of Glycosylation in the Fc Region of Therapeutic Recombinant Monoclonal Antibody

Confident Pesticides Analysis with the Agilent LC/Triple Quadrupole and TOF/QTOF Solutions

Disulfide Linkage Analysis of IgG1 using an Agilent 1260 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column

A High-Resolution, Accurate-Mass Approach for Ultra-High Throughput Screening Plasma Protein Binding

Algorithm for Matching Additional Spectra

Lebedev A, 1 Damoc E, 2 Makarov A, 2 Samguina T 1 1. Moscow State University, Moscow, Russia; 2 ThermoFisher Scientific, Bremen, Germany

AB SCIEX TripleTOF 5600 SYSTEM. High-resolution quant and qual

Featuring Analyst software under Windows NT for enhanced performance and ease of use. API 150EX. LC/MS System

CQA Assessment by Peptide Mapping Using LC/MS with an AdvanceBio Peptide Plus Column

Low pg/ml Detection of rhuepos in Horse Plasma Employing High-Resolution MS

Exploring Extra Sensitivity Using ionkey/ms with the Xevo G2-XS Q-Tof HRMS for Small Molecule Pharmaceutical Analysis in Human Plasma

How to view Results with Scaffold. Proteomics Shared Resource

Thermo Scientific TSQ Quantum Access MAX

Peptide Mapping of Glycoprotein Erythropoietin by HILIC LC/MS and RP-LC/MS

HepG2 Labeling and Cell Growth Protocol for IROA Phenotypic Metabolic Profiling

About OMICS Group Conferences

Fast mass transfer Fast separations High throughput and improved productivity Long column lifetime Outstanding reproducibility Low carryover

Utilizing novel technology for the analysis of therapeutic antibodies and host cell protein contamination

Proteomics Technology Note

Thermo Scientific Mass Spectrometric Immunoassay (MSIA) Pipette Tips. Next generation immunoaffinity. Robust quantitative platform

HDX-MS at Waters Waters Corporation 1

Application Note. Author. Abstract. Biopharmaceuticals. Verified for Agilent 1260 Infinity II LC Bio-inert System. Sonja Schneider

Investigating Biological Variation of Liver Enzymes in Human Hepatocytes

Hongwei Xie, Martin Gilar, and John C. Gebler Waters Corporation, Milford, MA, U.S.A. INTRODUCTION EXPERIMENTAL

SEC-MS with Volatile Buffers for Characterization of Biopharmaceuticals

Analysis of Illegal Dyes in Food Matrices Using Automated Online Sample Preparation with Liquid Chromatography-Mass Spectrometry

TechnicalNOTE METABOLYNX EXACT MASS DEFECT FILTER: RAPIDLY DISCRIMINATE BETWEEN TRUE METABOLITES AND FALSE POSITIVES INTRODUCTION

HIC as a Complementary, Confirmatory Tool to SEC for the Analysis of mab Aggregates

Practical Tips. : Practical Tips Matrix Science

Fraction Analysis of Cysteine Linked Antibody-Drug Conjugates Using Hydrophobic Interaction. chromatography. Agilent 1260 Infinity II Bio-Inert System

Increasing MS Sensitivity for Proteomics

Heart-cut 2D-LC/MS approach for pharmaceutical impurity identification using an Agilent 6540 Q-TOF LC/MS System

Thermo Scientific BioLC Columns. Monoclonal antibody. characterization

Application Note. Authors. Abstract

Improved Peptide Maps Using Core-Shell Media: Explaining Better Biopharmaceutical Applications With Kinetex C18 Columns

Modification Site Localization Scoring Integrated into a Search Engine

Agilent 6490 Triple Quadrupole LC/MS System REACH ULTIMATE SENSITIVITY WITH BREAKTHROUGH IFUNNEL TECHNOLOGY

LC/MS Analysis of the Monoclonal Antibody Rituximab Using the Q Exactive Benchtop Orbitrap Mass Spectrometer

Advanced QA/QC characterization MS in QC : Multi Attribute Method

Transcription:

Fourier-Transform MS for Top Down Proteomics Proteomics Team @ Northwestern University Thermo User Meeting, December 9 th, 2015 Hosted by Thermo Fisher Scientific Odense, Denmark

On the Use of Top Down Proteomics in Targeted and Discovery Mode C & E News Webinar, October 26 th, 2015 Sponsored by Thermo Fisher Scientific

Executive Summary Orbitrap Fusion Lumos MS Features and Demonstrations Complete Characterization of Human Histone H3 Retuximab and EDC Characterization onthe-fly TD and MD (IdeS) on a Chromatographic Time Scale Top Down Proteomics Updates and Future Direction Proteoform Identification and Characterization Proteoform Quantitation (0-30 kda)

Top Down Proteomics: Measuring Intact Proteins

The proteoform: Cannonical Sequence (UniProtKB) Endogenous proteolysis mrna splicing Mutations SNPs A distinct molecular form of a protein product arising from a single gene -- The Consortium for Top Down Proteomics Site specific features -govern activity, localization, interactions, half-life Consortium for Top Down Proteomics, Nat. Methods, 2013

Overview of Orbitrap Fusion Lumos MS for Top Down (b) New Orbitrap Tribrid mass spectrometer: Orbitrap Fusion Lumos MS ETD HD Advanced Quadrupole Technology Advanced Active Ion Beam Guide Advanced Vacuum Technology Electrodynamic Ion Funnel High Capacity Transfer Tube

Overview of Orbitrap Fusion Lumos MS for Top Down (b) New Orbitrap Tribrid mass spectrometer: Orbitrap Fusion Lumos MS Advanced Active Ion Beam Guide High Capacity Transfer Tube Electrodynamic Ion Funnel High Capacity Transfer Tube

Area Area Overview of Orbitrap Fusion Lumos MS for Top Down (b) New Orbitrap Tribrid mass spectrometer: Orbitrap Fusion Lumos MS Letter Box Inlet 2-5x Improvement Enhanced Sensitivity In Sensitivity 1.0E+06 Enhanced 1.0E+08 Enhanced 1.0E+05 Classic y = 123.8x R² = 0.9992 1.0E+07 1.0E+06 Classic y = 96.788x R² = 0.9985 1.0E+04 y = 26.934x R² = 0.9989 1.0E+05 y = 51.111x R² = 0.9999 1.0E+03 1.0E+04 Advanced Active Ion Beam Guide 1.0E+02 1.000 10.000 100.000 1000.000 Injection (fg) 1.0E+03 10 100 1000 10000 100000 Injection (fg) Electrodynamic Ion Funnel High flow Alprazolam dilution series 5x improvement in sensitivity 27 Proprietary & Confidential High Capacity Transfer Tube Low flow AEFVEVTK dilution series 2x improvement in sensitivity

60 Overview of Orbitrap Fusion 90 Lumos MS for Top Down 30 (b) New Orbitrap Tribrid mass spectrometer: 100 80 60 Orbitrap Fusion Lumos MS Advanced Quadrupole Technology Relative Abundance Relative Abundance Relative Relative Abundance Abundance Relative Abundanc Relative Abundance 100 80 50 70 100 80 40 60 90 70 50 20 40 70 90 50 10 30 60 80 40 20 100 50 70 0 30 10 90 40 60 20 100 0 80 30 50 10 NTKO_H3.1_full_60k #1 RT: 0.00 AV: 1 NL: 2.24E6 T: FTMS + p NSI Full ms [500.00-1500.00] 854.09 z=18 100 95 90 85 80 75 70 65 60 55 50 45 40 35 30 25 20 15 10 5 0 70 90 20 40 100 0 60 80 10 30 90 50 70 20 100 0 80 40 60 10 90 70 30 50 100 80 0 60 20 40 70 90 50 10 30 60 80 40 20 0 50 70 30 10 40 60 20 0 30 50 10 848.33 z=? 850 855 860 865 870 m/z 20 400 10 30 200 10 0 853.43 z=18 852.59 z=18 852.43 z=18 851.76 z=18 851.09 z=18 850.31 z=18 854.93 z=18 855.09 z=18 856.43 z=18 857.20 z=18 857.98 z=18 859.65 z=18 ETD Histone HD H3.1 High Transmission at < 1 Th Isolation Windows 861.31 z=18 863.48 z=18 865.49 867.49 z=? z=? Advanced Vacuum Technology 849 850 851 852 853 8 m/z 849 850 851 852 853 8 m/z 849 850 851 852 853 8 m/z 849 850 851 852 853 m/z 849 850 851 852 853 m/z

Overview of Orbitrap Fusion Lumos MS for Top Down (b) New Orbitrap Tribrid mass spectrometer: Orbitrap Fusion Lumos MS ETD HD ETD HD of Intact Monoclonal Antibody Unmatched S:N for ETD Fragment Ions High Capacity Transfer Tube

Overview of Orbitrap Fusion Lumos MS for Top Down (b) New Orbitrap Tribrid mass spectrometer: Orbitrap Fusion Lumos MS Isotopically Resolved Light Chain Isotopic Resolution on Larger Molecules with Higher Sensitivity Advanced Quadrupole Technology Advanced Active Ion Beam Guide Advanced Vacuum Technology Electrodynamic Ion Funnel High Capacity Transfer Tube

New Tribrid Lumos MS and ProSight Allow Complete Characterization of Human Histone H3 MS1 Spectrum of Histone H3.1 Fragment Ion Map 7 methylations: K9me2K18me1K27me2K36me2 Quadrupole Isolation (0.6 Th) Isolated Precursors p-score: 4 x 10-64 Proteoform Score: 730 ProSightPD or (Xtract + ProSight Lite) (Fellers R, et al, Proteomics 15:1235, 2015) ETD-HD 100 90 80 MS2 ETD Spectrum 855.65 z=18 906.04 z=17 NL: 1.47E histone_h3 _810.7_hc FTMS + p 810.7000@ [300.0000 Relative Abundance 70 60 50 40 30 20 10 346.22 z=1 367.57 z=3 465.78 z=2 474.31 z=1 810.56 z=19 543.85 z=2 587.36 z=2 703.42 z=1 655.39 z=2 737.44 z=? 774.46 z=1 961.67 z=16 1025.64 z=15 1094.69 z=? 1184.66 z=? 1273.71 z=1 1397.32 z=? 0 100 905.98 z=17 NL: 5.93E Histone_H _810.7_NO

Isolating Proteoforms of Histone H3.1 (e.g., with 8 Methylations) Quad Isolate: 0.6 Th

Isolating Proteoforms of Histone H3.1 (e.g., with 8 Methylations) Quad Isolate: 0.6 Th

Isolating Proteoforms of Histone H3.1 (e.g., with 8 Methylations) Quad Isolate: 0.6 Th

Characterizing Histone H3.1 Proteoforms with 7 Methylations: ETD-HD + EThCD

Characterizing Histone H3.1 Proteoforms with 7 Methylations: ETD-HD + EThCD

Characterizing Histone H3.1 Proteoforms with 7 Methylations: ETD-HD + EThCD C28 Ion Me5 Me4 Me2 Me3 Me6 Me7

Dr. Yupeng Zheng Unabridged Analysis of Human Histone H3 by Differential Top-Down Mass Spectrometry Reveals Hypermethylated Proteoforms from MMSET/NSD2 Overexpression. Mol. Cell. Proteomics. 2015 Aug 13. mcp.m115.053819. [Epub ahead of print] Dr. Luca Fornelli

Improved Top-Down and Middle-Down Characterization of Complex Biopharmaceuticals on a Modified Tribrid Mass Spectrometer Dr. Luca Fornelli Dr. Philip Compton

TOP DOWN PROTEOMICS: RECENT PROGRESS

Executive Summary on TDPs: Proteoform-Resolved Measurements are Proving Powerful and Valuable Protein Identification and Proteoform Characterization (Can now do thousands in a week ) Proteoform Quantitation now possible (0-30 kda); 30-60 kda range coming soon... New Metrics for Proteoform Scoring

Top Down Proteomics of >1000 Proteins, >3000 Proteoforms Tran, Kelleher, et al., Nature 2011; 480:7376, p. 254

Reducing Top Down to Practice, circa 2012

The Best Top Down Platform, 2015 and beyond

Top Down Proteomics of Mouse Xenografts (PDX) WHIM 2 WHIM 2 WHIM 16 WHIM 16 Ntai, Kelleher, et al., Mol. Cell. Proteom. In Review

GELFrEE Separation of Human Cell Extract 50 37 25 60 Files HCD/ETD/CID DD 18 Files Med-High-HCD 20 15 34 Files 16 HCD DD 28 High-High HCD 10

Analysis of a Single Enriched Mitochondrial GELFrEE Fraction 153 unique protein IDs 218 proteoforms 67 membrane proteins Catherman, A.D. et al., Mol. Cell. Proteomics, 2013, in press. 28

ETD for PTM Localization on Integral Membrane Proteins For further discussion of integral membrane protein fragmentation see Owen Skinner, TP 008 29

The High Mass Problem Large proteins have poor chromatographic properties Top-down LC/MS tends to identify smaller proteins Tran et al., Nature 2011, 480:254 258 30

1. Platform for efficient characterization of biotherapeutics (a) LC-MS/MS Efficient IgG desalting/fragment separation Minimal sample manipulation Denaturing conditions: reverse phase chromatography (H 2 O/ACN) Monolithic columns (Thermo Scientific), 200 µm i.d., 250 mm, 10 µl/min flow rate RP-5H (C4) New! RP-4H (ethylvinylbenzene/divinylbenzene) Kelly Flook Shane Bechler Yury Agroskin 31

Intact Protein Separations Yury Agroskin Kelly Flook Neil Kelleher Shane Bechler Kihun Kim Ioanna Ntai

Extended mass range for top-down proteomics (these are IT data)

Improved intact protein separations ~50-65 kda proteins 47 gene products 94 proteoforms 64 gene products 149 proteoforms

Comparison of RP-4H F2 25cm and RP- RT: 0.00-80.02 6.16 100 6.64 80 60 40 20 0 100 80 60 40 20 0 5.64 4H F2 50cm fraction 6 37.08 5.10 37.49 24.97 38.90 46.13 4.70 31.60 36.50 10.15 24.62 11.38 47.34 53.26 64.86 67.80 14.44 16.64 53.75 2.47 69.14 78.22 13.27 27.16 40.59 39.84 0 10 20 30 40 50 60 70 80 Time (min) 45.53 48.78 6.33 6.62 56.10 5.63 26.89 33.82 54.12 56.48 49.48 RP-4H 25cm 99 gene products 116 proteoforms RP-4H 50cm 101 gene products 136 proteoforms 16.68 25.27 66.48 19.13 57.87 24.73 69.11 70.47 NL: 7.26E6 Base Peak F: FTMS + p NSI sid=15.00 Full ms [500.00-2000.00] MS 20130623_RP- 4H_100umIDx25cm_HeLa _GF06 NL: 5.96E6 Base Peak F: FTMS + p NSI sid=15.00 Full ms [500.00-2000.00] MS 20130624_RP- 4H_100umIDx50cm_HeLa _GF06

RT: 0.00-130.13 100 90 80 70 Comparison of different gradient lengths with the RP-4H 100cm F2 at 0.4µl/min flow rate (fraction 8) 42.78 46.94 62 gene products 371 proteoforms NL: 1.89E7 Base Peak F: ITMS + p NSI sid=15.00 Full ms [500.00-2000.00] MS 20130714_RP- 4H_100umIDx100cm_110mi n_hela_gf08 60 50 40 39.62 49.55 50.63 30 31.86 38.25 20 10 0 100 90 80 70 60 50 40 30 20 10 0 2.26 5.56 17.33 18.13 37.56 28.79 24.32 53.17 55.78 16.27 18.80 58.48 15.13 69.40 70.78 75.18 76.65 59.78 67.41 51.50 52.90 58.62 63.33 57.85 49.88 73.33 79.65 46.93 40.19 80.11 43.57 91.17 26.93 39.96 84.17 35.79 89.55 13.79 15.27 17.91 120.69 9.56 22.43 92.55 99.50 104.79 112.79 8.07 119.70 125.22 0 10 20 30 40 50 60 70 80 90 100 110 120 130 Time (min) 67.94 85 gene products 581 proteoforms NL: 2.34E7 Base Peak F: ITMS + p NSI sid=15.00 Full ms [500.00-2000.00] MS 20130714_RP- 4H_100umIDx100cm_160mi n_hela_gf08

Column and Operating Parameters Column Flow rate Column temperature Eluents Injection PLRP-S 1000 Å 5μ Analytical (100 μm ID 25 cm) Loading 1.5 μl/min Gradient 1 μl/min 40 C RP-4H Analytical (100 μm ID 50 cm) Loading 1.5 μl/min Gradient 1 μl/min A 95% H 2 O/5% ACN + 0.1% Formic Acid B 5% H 2 O/95% ACN + 0.1% Formic Acid 6 μl (standards), 5 μl (GELFrEE fractions)

Comparison of RP-4H F2 25cm and RP- RT: 0.00-80.02 6.16 100 6.64 80 60 40 20 0 100 80 60 40 20 0 5.64 4H F2 50cm fraction 6 37.08 5.10 37.49 24.97 38.90 46.13 4.70 31.60 36.50 10.15 24.62 11.38 47.34 53.26 64.86 67.80 14.44 16.64 53.75 2.47 69.14 78.22 13.27 27.16 40.59 39.84 0 10 20 30 40 50 60 70 80 Time (min) 45.53 48.78 6.33 6.62 56.10 5.63 26.89 33.82 54.12 56.48 49.48 RP-4H 25cm 99 gene products 116 proteoforms RP-4H 50cm 101 gene products 136 proteoforms 16.68 25.27 66.48 19.13 57.87 24.73 69.11 70.47 NL: 7.26E6 Base Peak F: FTMS + p NSI sid=15.00 Full ms [500.00-2000.00] MS 20130623_RP- 4H_100umIDx25cm_HeLa _GF06 NL: 5.96E6 Base Peak F: FTMS + p NSI sid=15.00 Full ms [500.00-2000.00] MS 20130624_RP- 4H_100umIDx50cm_HeLa _GF06

Comparison of RP-4H F2 25cm and RP- RT: 0.00-80.09 100 80 60 40 20 4H F2 50cm fraction 9 22.72 22.49 33.94 32.08 31.30 29.67 34.87 37.42 47.59 RP-4H 25cm 15 gene products 70 proteoforms 38.58 39.58 47.98 21.79 53.07 20.23 53.30 10.84 6.25 54.15 60.02 64.53 69.16 NL: 1.09E7 Base Peak F: ITMS + p NSI sid=15.00 Full ms [500.00-2000.00] MS 20130623_RP- 4H_100umIDx25cm_HeLa _GF09 0 100 80 60 12.75 70.84 78.95 30.56 36.32 34.93 40.48 42.33 51.86 RP-4H 50cm 59 gene products 273 proteoforms NL: 2.24E7 Base Peak F: ITMS + p NSI sid=15.00 Full ms [500.00-2000.00] MS 20130624_RP- 4H_100umIDx50cm_HeLa _GF09 40 20 0 44.95 45.10 53.86 27.68 25.66 54.47 13.74 57.47 6.50 24.79 66.26 70.68 72.94 0 10 20 30 40 50 60 70 80 Time (min)

TOP DOWN PROTEOMICS: FUTURE DIRECTIONS

Recent Progress on Proteoform-Resolved Measurements

Top Down Label-free Quantitation Ntai et al. Anal. Chem. 2014.

3 Measurement Functions of Top Down Proteomics Protein Identification Characterization of Proteoforms Quantitation of Proteoforms Can Now Keep Score for Each

Key Metrics for Top Down Proteomics - Identification: p-value, E-value, or q-value - Proteoform Characterization Score (PCS), or C-Score for short PCS: 730 (scale is 0-1000+) - Quantitation Confidence (instantaneous q-value, ANOVA)... and... How many Proteoforms are fragmented?... and how well? Swiss-Prot Accession No: P00000 p-value: 4 x 10-64

Report 4 things in Top Down Searches of the Future: 1. the UniProt Accession Number associated with the I.D.. 2. E-value (or Q-value) - some metric of confidence for the I.D. 3. The Proteoform repository identifier : (e.g. PFR2000374) associated with the proteoform. 4. a C-Score - metric of confidence for the proteoform

Statistical Metrics for classifying a hit in Top Down Proteomics

The C-Score : Improving Proteoform Characterization

Metrics of All 3 should be very high on the Orbitrap Fusion Lumos MS - Identification: p-value, E-value, or q-value - Proteoform Characterization Score (PCS), or C-Score for short PCS: 730 (scale is 0-1000+) - Quantitation Confidence (instantaneous q-value, ANOVA)... and... How many Proteoforms are fragmented?... and how well? Swiss-Prot Accession No: P00000 p-value: 4 x 10-64

Top Down Proteomics: 2 Big Ideas

The Proteoform Hypothesis (It s About Tighter Correlations to Phenotype) 2 proteoforms 1 proteoform 3 peptides 2 peptides 1 peptide Proteoforms in Translational Research Need for N and Strategic Alignment with Population and Genomic-Based Medicine

Organ/Tiss ue Cells Organelles Protein Complexes Protein Molecules

Conclusions Orbitrap Fusion Lumos MS is suitable for both top-down MS of intact 150 kda abs and middle-down MS of ~25 kda ab fragments on the LC time scale ETD HD improved substantially the S/N ratio of MS/MS spectra (~3-fold improvement) Lumos MS technology allowed the characterization of EDC through: Mass determination of both non-isotopically and isotopically resolved EDC fragments Localization of conjugation sites by ETD HD 52

Acknowledgments 53

Sponsors and Supporters of the Proteomics Center at Northwestern